Brenda Raphael brings deep experience in the Pharmaceutical industry from wide-ranging leadership roles in new product and pre-launch commercialization, general management of multi-therapeutic area portfolios, leadership of over-the-counter medicines, and brand leadership of products across several therapeutic areas. In this capacity she’s led sales, marketing, operations, and other functions to drive both top line and bottom line. Her teams develop and execute commercialization strategies across all customer groups, as well as bring to market everything from consumer advertising to physician education for the products in her portfolio. She has both a savvy business mind as well as a keen drive to ensure her portfolios use the strongest marketing and commercialization strategies. She came early to digital marketing, and strives to adapt and adopt marketing strategies that can be effective wherever the brand audience may be. Brenda is known as a keen strategist as well as someone dedicated to building strong teams that continue to grow personally and professionally.
Brenda comes to this work from a deep base of experience in marketing at Pfizer, Bayer Consumer, and Novartis where she has held several roles of increasing responsibility across many categories. She’s no stranger to household names, however, having worked on mega-brands from Coca-Cola to Cheer laundry detergent at her previous roles at the Coca-Cola Company and Procter & Gamble where she has led teams in both digital and traditional marketing.
She is a graduate of Cornell University and holds an MBA from the Darden School at the University of Virginia. She lives outside of New York in Westchester county with her husband, two children, and a dog named Maisy BoBo.
Kate Miller Named Chief Strategy Officer at Evolution Road
Kate Miller has been promoted to the position of Chief Strategy Officer from the position of Digital Innovation/Commercialization Practice Lead. She has been with the firm for nearly 14 years and was previously the Vice President of Strategy. Kate will be responsible for ER’s market vision, positioning and branding, thought leadership and intellectual property.
August 30, 2021
Announcing Decoding Digital Health for Life Sciences
The ER team is pleased to invite you to a new industry event called Decoding Digital Health for Life Sciences, running June 15-16, 2021. This event will help Life Science brand and commercial teams better understand the digital health opportunity and how to leverage digital health to improve patient outcomes and drive commercial success. Decoding Digital Health was co-created by Evolution Road and ER's own Paul Ivans & Todd Kolm are the conference co-chairs.
April 20, 2021
Using big data to boost engagement, conversion and revenue
One of the country’s largest pharmaceutical companies and a top health information technology company had always wanted to work together, yet the right opportunity never presented itself. Taking an independent, objective view, we found one driven by data.
With the objective of driving awareness and education across an entire portfolio and, ultimately, incremental treatment rates and improved patient outcomes, we layered multiple data sources to inform a multi-pronged digital communications strategy that reached three million patients and drove $40 million in incremental revenue.
March 23, 2021
Reimagining patient engagement
A multinational pharmaceutical manufacturer knew there was room to improve engagement and adherence amongst its diabetes patients.
Where standard approaches fell short, we created the digital strategy, guided program development and piloted a multi-touch engagement program designed to meet patients on their terms—with deep personalization and less friction.
March 23, 2021
Eliminating care gaps through digital innovation
One of the world’s top pharmaceutical companies sought to narrow gaps in care across its entire vaccine portfolio.
Cultivating a collaborative partnership for our client with CareSpeak, an OptimizeRx company that offers an interactive health messaging platform, we crafted a comprehensive member communications strategy that sparked measurable, meaningful engagement.
March 22, 2021
Telemedicine is here to stay: How the barriers are breaking down
Historically, telemedicine has been impeded by three main barriers: applicability, lack of insurance coverage, and technology. However, with COVID and innovation as accelerators, telemedicine is breaking through.
February 3, 2021
Realizing the Promise of Digital Health Partnerships
Why have commercial life sciences, with a track record of going it alone, pivoted to partnerships with the Digital Health Ecosystem? How might a life science marketer get their organization primed for more/better partnering? How is the success of a partnership measured? What are some of the key watchouts in partnering?
December 18, 2020